Basilea Pharmaceutica Ltd. at its AGM held on April 13, 2022 approved appointment of Leonard Kruimer as new member of the Board, Following the election at the AGM, the Board appointed him as the Chairman of the Audit Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.1 CHF | +0.35% | +7.21% | +22.10% |
May. 03 | Basilea Reports Presentation of New Data for Ceftobiprole (Zevtera®) At Escmid Global 2024 | CI |
Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.10% | 572M | |
+25.82% | 44.96B | |
-0.83% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.46% | 26.08B | |
-21.14% | 19.03B | |
+6.03% | 12.75B | |
+28.44% | 12.06B | |
-3.24% | 11.75B |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG
- Basilea Pharmaceutica Ltd. Approves Appointment of Leonard Kruimer as New Member of Board and as Chairman of the Audit Committee